Nils Elander

Publikationer

2024

Karin Almlöv, Gunnar Arbman, Bergthor Björnsson, Nils Elander, Jakob Hager, Salik Hamid, Kalle Landerholm, Per Loftås, Per Sandström (2024) Assessment by a multidisciplinary team conference affects treatment strategy and overall survival in patients with synchronous colorectal liver metastases HPB, Vol. 26, s. 1131-1140 (Artikel i tidskrift) Vidare till DOI

Bengt Glimelius, Tanweera Khan, Karin Adolfsson, Eva Angenete, Ake Berglund, Kristina Bonde, Nils Elander, Tone Fokstuen, Johan Haux, Israa Imam, Cecilia Lagerback, Ingrid Ljuslinder, Andrzej Piwowar, Marie Zajicova, PerJ. Nilsson (2024) Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US) eClinicalMedicine, Vol. 75, Artikel 102771 (Artikel i tidskrift) Vidare till DOI

Knut Jorgen Labori, Svein Olav Bratlie, Bodil Andersson, Jon-Helge Angelsen, Christina Biorserud, Bergthor Björnsson, Erling Audun Bringeland, Nils Elander, Herish Garresori, Jon Erik Gronbech, Johan Haux, Oskar Hemmingsson, Maria Gustafsson Liljefors, Tor Age Myklebust, Linn Save Nymo, Katriina Peltola, Per Pfeiffer, Ville Sallinen, Per Sandström, Ernesto Sparrelid, Helge Stenvold, Kjetil Soreide, Bobby Tingstedt, Caroline Verbeke, Daniel Ohlund, Leif Klint, Svein Dueland, Kristoffer Lassen (2024) Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial The Lancet Gastroenterology & Hepatology, Vol. 9, s. 205-217 (Artikel i tidskrift) Vidare till DOI

2023

Hakon Blomstrand, Hans Olsson, Henrik Green, Bergthor Björnsson, Nils Elander (2023) Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort study HPB, Vol. 25, s. 1531-1544 (Artikel i tidskrift) Vidare till DOI

Roger Olofsson Bagge, Axel Nelson, Amir Shafazand, Charlotta All-Eriksson, Christian Cahlin, Nils Elander, Hildur Helgadottir, Jens Folke Kiilgaard, Sara Kinhult, Ingrid Ljuslinder, Jan Mattsson, Magnus Rizell, Malin Sternby Eilard, Gustav J. Ullenhag, Jonas A. Nilsson, Lars Ny, Per Lindner (2023) Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial) Journal of Clinical Oncology, Vol. 41, s. 3042-+ (Artikel i tidskrift) Vidare till DOI